Evidence map›Paper›PMID 41113173›Full record

ArticleIn silico pharmacology2025

Pentacyclo-icosan-19'-one compound from

Manoharan Harini, Arumugam Rajalakshmi, Kuppuswamy Kavitha, Sampath Harikumar, Veerasamy Guruchandran, Rajamanickam Baskar, Rengarajulu Puvanakrishnan, Balasubramanian Ramesh

Abstract read
In one paragraph

Article in In silico pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Manoharan HariniPG and Research Department of Biotechnology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu 631561 India.ORCID 0009-0001-8459-3274
Arumugam RajalakshmiPG and Research Department of Biotechnology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu 631561 India.ORCID 0000-0003-2216-3153
Kuppuswamy KavithaPG and Research Department of Microbiology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu 631561 India.ORCID 0000-0002-6892-9399
Sampath HarikumarPG and Research Department of Biotechnology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu 631561 India.ORCID 0009-0001-8400-1208
Veerasamy GuruchandranPG and Research Department of Biotechnology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu 631561 India.ORCID 0000-0003-1499-5670
Rajamanickam BaskarDepartment of Gunapadam (Pharmacology), Government Siddha Medical College, The Tamil Nadu Dr. MGR Medical University, Chennai, Tamil Nadu 600032 India.ORCID 0009-0002-0662-4837
Rengarajulu PuvanakrishnanPG and Research Department of Biotechnology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu 631561 India.ORCID 0000-0002-2662-5653
Balasubramanian RameshPG and Research Department of Biotechnology, Sri Sankara Arts and Science College, University of Madras, Enathur, Kanchipuram, Tamil Nadu 631561 India.ORCID 0000-0003-0890-3178

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global resurgence of the monkeypox virus (MPXV) poses a serious threat to public health, necessitating the development of potent antiviral compounds. This study explored the potential of MPXV H1 phosphatase inhibitors using a computational biology approach, leveraging traditional knowledge from Indian Materia Medica. An in-house library of approximately 50,000 natural compounds from Indian Materia Medica was screened using molecular docking techniques, identifying 12,800 compounds with significant binding affinities, including ten hit compounds selected for further analysis. The top three hit compounds exhibited binding affinities as low as - 8.2 kcal/mol, surpassing the positive controls, Antimycin A (- 6.1 kcal/mol) and Tecovirimat (- 7.0 kcal/mol). These compounds were further optimized using Density Functional Theory (DFT), showing their significant electronic properties and redocked with the target. Molecular dynamics (MD) simulation demonstrated the structural stability of lead 3 and target complex over 200 ns with - 96.02 ± 1.00 kJ/mol binding energy, significantly outperforming the control Antimycin A (- 23.59 ± 2.97 kJ/mol) and Tecovirimat (- 49.07 ± 1.46 kJ/mol). These findings suggest that Lead 3 containing

Indexed as

Density functional theoryH1 phosphatase inhibitorsIndian Materia MedicaMolecular dockingMolecular dynamics simulationMonkeypox virus (MPXV)

Identifiers

PMID41113173
PMCPMC12534649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.